Prevention of Sudden Cardiac Death With Implantable Cardioverter-Defibrillators in Children and Adolescents With Hypertrophic Cardiomyopathy
about
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of theHypertrophic cardiomyopathy.Optogenetics design of mechanistically-based stimulation patterns for cardiac defibrillation.Risk factors for sudden cardiac death in childhood hypertrophic cardiomyopathy: A systematic review and meta-analysis.Predictors of Long-Term Outcome in Children with Hypertrophic Cardiomyopathy.Almanac 2014: cardiomyopathies.Implantable cardioverter-defibrillator implantation for primary and secondary prevention: indications and outcomes.Device therapy in children with and without congenital heart disease.Extended Septal Myectomy for Hypertrophic Obstructive Cardiomyopathy in Children and Adolescents.Appropriate Implantable Defibrillator Therapy in Adults With Hypertrophic Cardiomyopathy.Midterm Results of Implantable Cardioverter Defibrillators in Children and Young Adults from a Single Center in Turkey.Incremental benefit of late gadolinium cardiac magnetic resonance imaging for risk stratification in patients with hypertrophic cardiomyopathy.Patient understanding of disease and the use and outcome of implantable cardioverter defibrillators in hypertrophic cardiomyopathy.ESC sudden-death risk model in hypertrophic cardiomyopathy: Incremental value of quantitative contrast-enhanced CMR in intermediate-risk patients.Long-term outcome of epicardial implantable cardioverter-defibrillator systems in children: results justify its preference in paediatric patients.Ventricular Tachyarrhythmias in Patients With Hypertrophic Cardiomyopathy and Defibrillators: Triggers, Treatment, and Implications.Arrhythmic Burden and Ambulatory Monitoring of Pediatric Patients with Cardiomyopathy.
P2860
Q28087002-83F7FCD1-D045-4345-9CE7-72B0D930CCEFQ30239034-480E6EDA-D225-4EF3-A2B5-A835CFD571F1Q30823202-6B92A35E-4909-45B9-9819-4D950A675CACQ33168599-877E60FE-89CE-4852-ABA8-2BF951DA9985Q36762345-E00D81AB-5F84-49A7-958B-C94BADC70AA9Q38193960-1821CC99-1C36-45DB-9770-F812C8C367C4Q39085632-25223A04-F5D7-44E1-8CE9-7109BAAFE071Q39152372-1CFCCE1E-2371-43F9-86C1-C92B60D0CA86Q39782589-05AEE069-DA28-4253-B41B-2642D711B421Q39801126-BB74A614-C1C6-465B-BDB0-0E0D5D6E54EFQ40480249-4A0B9A1F-E040-406C-BE36-F02D7094AABDQ41109592-42FFECBA-5BEF-49FB-94B6-91B6943158D3Q47445769-D76E358A-BF20-4BDA-89CA-E261488F3661Q47801890-408BED24-B180-4804-A4D6-AC73BF681C5BQ49668332-0949F408-BD71-4915-8A29-A23251F82628Q50988516-5BC15186-9636-4195-829E-6096EE84F1A9Q51474395-D6ACA06A-8744-4E39-B825-55AFB67C41EE
P2860
Prevention of Sudden Cardiac Death With Implantable Cardioverter-Defibrillators in Children and Adolescents With Hypertrophic Cardiomyopathy
description
article
@en
im April 2013 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 2013
@uk
name
Prevention of Sudden Cardiac D ...... th Hypertrophic Cardiomyopathy
@en
Prevention of Sudden Cardiac D ...... th Hypertrophic Cardiomyopathy
@nl
type
label
Prevention of Sudden Cardiac D ...... th Hypertrophic Cardiomyopathy
@en
Prevention of Sudden Cardiac D ...... th Hypertrophic Cardiomyopathy
@nl
prefLabel
Prevention of Sudden Cardiac D ...... th Hypertrophic Cardiomyopathy
@en
Prevention of Sudden Cardiac D ...... th Hypertrophic Cardiomyopathy
@nl
P2093
P50
P1476
Prevention of sudden cardiac d ...... th hypertrophic cardiomyopathy
@en
P2093
Adrian K Almquist
Aristidis Anastasakis
Barry J Maron
Emmanuela Devoto
Euan A Ashley
Francesco Formisano
J Martijn Bos
Kevin M Shannon
P304
P356
10.1016/J.JACC.2013.01.037
P407
P577
2013-04-01T00:00:00Z